From: The effects of DNA formulation and administration route on cancer therapeutic efficacy with xenogenic EGFR DNA vaccine in a lung cancer animal model
Vaccine group
CD4+ T cells
CD8+ T cells
Control
6 ± 1
0
i.m
17 ± 2**
11 ± 5#
g.g -DNA coated gold particles
118 ± 24***
4 ± 3#
g.g-non coating DNA
7 ± 2
23 ± 4##